CLEAN : Liberia: Trial for Potential Ebola Treatment Underway

The video discusses a treatment trial for Ebola in Liberia, focusing on the potential treatment brincidofovir (BCV). Patients with confirmed Ebola are screened and can voluntarily participate in the trial. Those who opt out receive standard care, while participants receive the trial medicine in addition to standard care. The trial aims to evaluate whether survival rates improve with the treatment compared to standard care alone.

What is the nature of participation in the trial for patients?

What is the primary outcome being measured in the trial?